Antibody discovery CRO **Baiying Biotech** closes nearly RMB 500 million Series B round
Specializing in antibody discovery CRO services to accelerate antibody drug development.
@gaorong
创造美好生活
Specializing in antibody discovery CRO services to accelerate antibody drug development.
The platform has served more than 1.5 million users worldwide and processes over RMB 350 billion in annual order transaction volume.
Focused on tackling XR-dedicated smart chips.
Dedicated to becoming a trailblazer in China's TRT space.
Evolution never stops, and neither does computation.
In the first half of 2022, order value doubled as the company accelerated global expansion and drove R&D innovation.
Major events in July.
Accelerating VCSEL chips' transition from consumer-grade to automotive-grade standards.
A one-stop CDMO platform for biologics R&D and manufacturing.
The growth of an organization is a miraculous journey of life.